SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,528,584 | +6.5% | 12,610 | +0.6% | 0.02% | +10.5% |
| Q2 2023 | $1,435,852 | -9.3% | 12,538 | +9.1% | 0.02% | -17.4% |
| Q1 2023 | $1,583,253 | +7.2% | 11,487 | +0.8% | 0.02% | -4.2% |
| Q4 2022 | $1,476,435 | +34.7% | 11,394 | +14.9% | 0.02% | +14.3% |
| Q3 2022 | $1,096,000 | +48.3% | 9,917 | +0.5% | 0.02% | +40.0% |
| Q2 2022 | $739,000 | +0.8% | 9,863 | +5.1% | 0.02% | +25.0% |
| Q1 2022 | $733,000 | -12.7% | 9,384 | +0.6% | 0.01% | -7.7% |
| Q4 2021 | $840,000 | +6.1% | 9,332 | +9.0% | 0.01% | -13.3% |
| Q3 2021 | $792,000 | +14.5% | 8,560 | -3.9% | 0.02% | +15.4% |
| Q2 2021 | $692,000 | +18.9% | 8,905 | +14.0% | 0.01% | +8.3% |
| Q1 2021 | $582,000 | -56.3% | 7,810 | -0.1% | 0.01% | -58.6% |
| Q4 2020 | $1,333,000 | +22.7% | 7,821 | +1.1% | 0.03% | +7.4% |
| Q3 2020 | $1,086,000 | -12.8% | 7,733 | -0.5% | 0.03% | -15.6% |
| Q2 2020 | $1,246,000 | – | 7,772 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |